Latest ROE for Tenon Medical- Warrants (16/06/2028): 783.99% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow783.99%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Tenon Medical- Warrants (16/06/2028)'s return on equity stands at 783.99%. That is above the sector sector average of -5.68%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Tenon Medical- Warrants (16/06/2028) sits higher the its sector benchmark (-5.68%) with a ROE of 783.99%. That is roughly 13896.7% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A ROE of 783.99% for Tenon Medical- Warrants (16/06/2028) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Tenon Medical- Warrants (16/06/2028)'s ROE evolved across reporting periods, while the comparison chart places TNONW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.